6185.HKEarnings Release财报快讯Source checked来源已核对Source link原始来源August 27, 20262026/8/27by InvestLog AIInvestLog AI 整理

CanSino Biologics Inc. (6185.HK) 2026 H1 financial resultsCanSino Biologics Inc. (6185.HK) 2026 H1 财报发布

Key Results

CanSino Biologics Inc. reported revenue CN¥547M, operating profit CN¥28M, net income -CN¥721,000, operating margin 5.0%.

Profitability and Cash Flow

Period: 2026 H1

Revenue: CN¥547M; YoY: +46.1%

Gross profit: CN¥413M; Gross margin: 75.6%; YoY: +39.4%

Operating profit: CN¥28M; Operating margin: 5.0%; YoY: +1347.1%

Net income: -CN¥721,000; Earnings per share: CN¥0.00; Net margin: -0.1%

Official release: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026

核心结果

CanSino Biologics Inc. 公布2026 H1财报：营收 CN¥547M，营业利润 CN¥28M，净利润 -CN¥721,000，营业利润率 5.0%。

财务指标

期间：2026 H1

营收：CN¥547M；同比 +46.1%

毛利润：CN¥413M；毛利率：75.6%；同比 +39.4%

营业利润：CN¥28M；营业利润率：5.0%；同比 +1347.1%

净利润：-CN¥721,000；每股收益：CN¥0.00；净利率：-0.1%

View 6185.HK stock details ->查看 6185.HK 个股详情 ->

This earnings research was prepared from company results, regulatory filings, and financial statements. It is for informational purposes only and does not constitute investment advice.这篇财报研究基于公司业绩公告、监管文件和财务报表整理。内容仅供参考，不构成投资建议。